위출혈 환자에서 관상동맥중재술 직후 발생한 급성 스텐트혈전증 = Simultaneous Multivessel Acute Stent Thrombosis in a Patient with Gastrointestinal Bleeding

다국어 초록 (Multilingual Abstract)

Stent thrombosis is a rare, but potentially catastrophic complication of stent implantation. Dual antiplatelet therapy with aspirin and a thienopyridine (clopidogrel, prasugrel, or ticagrelor) is essential to minimize the risk of stent thrombosis in patients receiving drug-eluting stents. However, there is an ongoing debate regarding antiplatelet therapy in patients presenting with acute coronary syndrome and bleeding. Here, we report a case of a 59-year-old man with acute stent thrombosis immediately after percutaneous coronary intervention combined with acute coronary syndrome and gastrointestinal bleeding. (Korean J Med 2016;90:322-325)

참고문헌 (Reference)

1 강민규, "최근 개발된 항혈소판제제" 대한내과학회 85 (85): 10-14, 2013

2 Engelmann B, "Thrombosis as an intravascular effector of innate immunity" 13 : 34-45, 2013

3 Sabovic M, "Plasminogen activator inhibitor-1, which is released from blood product transfusions, might be associated with(sub)acute thrombosis after coronary dilatation and stenting : a case report" 18 : 47-49, 2003

4 Alli O, "Incidence, predictors, and outcomes of gastrointestinal bleeding in patients on dual antiplatelet therapy with aspirin and clopidogrel" 45 : 410-414, 2011

5 Iakovou I, "Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents" 293 : 2126-2130, 2005

6 Silvain J, "Impact of red blood cell transfusion on platelet aggregation and inflammatory response in anemic coronary and noncoronary patients : the TRANSFUSION-2 study(impact of transfusion of red blood cell on platelet activation and aggregation studied with flow cytometry use and light transmission aggregometry)" 63 : 1289-1296, 2014

7 Hamm CW, "ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation : The Task Force for the management of acute coronary syndromes(ACS)in patients presenting without persistent ST-segment elevation of the European Society of Cardiology(ESC)" 32 : 2999-3054, 2011

8 Lüscher TF, "Drug-eluting stent and coronary thrombosis : biological mechanisms and clinical implications" 115 : 1051-1058, 2007

9 Sibbing D, "Cytochrome 2C19*17allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement" 121 : 512-518, 2010